|Intravenous adenosine and lidocaine in patients with acute myocardial infarction.|
|PMID: 9704679 Owner: NLM Status: MEDLINE|
|OBJECTIVES: A pilot study was designed to assess the safety of combined intravenous adenosine and lidocaine in patients with acute myocardial infarction and to estimate the likelihood of a beneficial effect on final infarct size.
BACKGROUND: Adenosine plus lidocaine reduces infarct size in animals, but the safety and efficacy in human beings is unknown.
METHODS AND RESULTS: Adenosine (70 microg/kg per minute intravenous infusion) plus lidocaine (1 mg/kg intravenous bolus injection and 2 mg/kg per minute infusion) was given to 45 patients with acute myocardial infarction. Patients underwent immediate balloon angioplasty without preceding thrombolytic therapy. Myocardial perfusion defects were measured with serial technetium 99m sestamibi studies. One patient developed persisting hypotension in conjunction with a large inferolateral myocardial infarction. Transient hypotension in three other patients resolved with a reduction in adenosine. Advanced atrioventricular block was never observed. Other adverse events (including atrial fibrillation, ventricular tachyarrhythmia, bradycardia, and respiratory distress) occurred at low frequencies, as expected for patients with acute myocardial infarction. An initial median perfusion defect of 45% of the left ventricle (60% for anterior infarction, 17% for nonanterior infarction) was observed. At hospital discharge (mean +/- SD = 4.3 +/- 2.1 days) the median value was 12%, and at 8 +/- 4 weeks it was 3% (7% for anterior infarction, 0% for nonanterior infarction); 14 patients had no measurable follow-up. Compared with historical control patients, prehospital discharge measurements were not different but late perfusion defects were improved.
CONCLUSIONS: Treatment with intravenous adenosine and lidocaine during acute myocardial infarction has sufficient safety and potential for improved myocardial salvage. Randomized studies are justified.
|K N Garratt; D R Holmes; V Molina-Viamonte; G S Reeder; D O Hodge; K R Bailey; J K Lobl; D A Laudon; R J Gibbons|
Related Documents :
|3761569 - Inotropic and chronotropic activity of a new cardiotonic agent, dm 9278 (1,2,3,4,8,9,10...
7471859 - Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and...
7191789 - Myocardial electrical instability after abrupt withdrawal of long-term administration o...
3080299 - A seizure induced by concurrent lidocaine-tocainide therapy--is it just a case of addit...
835719 - Effects of intravenous anesthetic agents on left ventricular function in dogs.
1355629 - Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in c...
1739049 - Thrombolytic therapy in acute myocardial infarction.
19076849 - Short-term effects of right ventricular pacing on cardiorespiratory function in patient...
21392609 - The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovasc...
|Type: Journal Article; Research Support, Non-U.S. Gov't|
|Title: American heart journal Volume: 136 ISSN: 0002-8703 ISO Abbreviation: Am. Heart J. Publication Date: 1998 Aug|
|Created Date: 1998-08-19 Completed Date: 1998-08-19 Revised Date: 2013-03-14|
Medline Journal Info:
|Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: UNITED STATES|
|Languages: eng Pagination: 196-204 Citation Subset: AIM; IM|
|Division of Cardiovascular Disease and Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn. 55905, USA.|
|APA/MLA Format Download EndNote Download BibTex|
administration & dosage*,
Angioplasty, Balloon, Coronary
Anti-Arrhythmia Agents / administration & dosage*, adverse effects
Combined Modality Therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Electrocardiography / drug effects
Hemodynamics / drug effects
Lidocaine / administration & dosage*, adverse effects
Myocardial Infarction / drug therapy*, radionuclide imaging
Myocardial Reperfusion Injury / prevention & control, radionuclide imaging
Technetium Tc 99m Sestamibi / diagnostic use
Tomography, Emission-Computed, Single-Photon
Vasodilator Agents / administration & dosage*, adverse effects
|0/Anti-Arrhythmia Agents; 0/Vasodilator Agents; 109581-73-9/Technetium Tc 99m Sestamibi; 137-58-6/Lidocaine; 58-61-7/Adenosine|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sex differences in symptom presentation associated with acute myocardial infarction: a population-ba...
Next Document: Sudden coronary death in women.